The article analyzes scientific publications (37 articles) devoted to phthisiology, clinical pharmacology of antimicrobial agents, laboratory methods for evaluating the effectiveness and safety of various regimens of tuberculosis chemotherapy caused by resistant strains of M. tuberculosis.It tells about prospects for expanding the line of antimicrobial agents for treatment of tuberculosis caused by resistant strains of M. tuberculosis, new approaches to the study and evaluation of the effectiveness of the drug at the stage of preclinical trials using the in vitro HFS-TV model
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
Tuberculosis (TB), an ongoing public health threat, is worsened by the emergence of drug resistance....
ABSTRACT- Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency...
Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional ...
Tuberculosis is still a major health problem worldwide. Although treatment regimens currently availa...
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people dying annual...
The article presents the review of 68 publications, recommendations, and guidelines on clinical tria...
A significant hazard to human health is tuberculosis infection, and in the early 21st century, the d...
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampi...
Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency virus (HI...
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective con...
The article is devoted to generalization of the ways to optimize the consumption of antibacterial an...
The most lethal disease tuberculosis is caused by Mycobacterium tuberculosis and the risk has worsen...
For the first time in 40 years, a portfolio of promising new compounds for the treatment of tubercul...
Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 mill...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
Tuberculosis (TB), an ongoing public health threat, is worsened by the emergence of drug resistance....
ABSTRACT- Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency...
Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional ...
Tuberculosis is still a major health problem worldwide. Although treatment regimens currently availa...
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people dying annual...
The article presents the review of 68 publications, recommendations, and guidelines on clinical tria...
A significant hazard to human health is tuberculosis infection, and in the early 21st century, the d...
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampi...
Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency virus (HI...
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective con...
The article is devoted to generalization of the ways to optimize the consumption of antibacterial an...
The most lethal disease tuberculosis is caused by Mycobacterium tuberculosis and the risk has worsen...
For the first time in 40 years, a portfolio of promising new compounds for the treatment of tubercul...
Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 mill...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
Tuberculosis (TB), an ongoing public health threat, is worsened by the emergence of drug resistance....
ABSTRACT- Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency...